208 related articles for article (PubMed ID: 24668465)
1. Systematic review and meta-analysis of the effectiveness and safety of extended lymphadenectomy in patients with resectable gastric cancer.
Jiang L; Yang KH; Chen Y; Guan QL; Zhao P; Tian JH; Wang Q
Br J Surg; 2014 May; 101(6):595-604. PubMed ID: 24668465
[TBL] [Abstract][Full Text] [Related]
2. Extent of lymph node dissection for adenocarcinoma of the stomach.
Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis of D1 versus D2 lymph node dissection.
Seevaratnam R; Bocicariu A; Cardoso R; Mahar A; Kiss A; Helyer L; Law C; Coburn N
Gastric Cancer; 2012 Sep; 15 Suppl 1():S60-9. PubMed ID: 22138927
[TBL] [Abstract][Full Text] [Related]
4. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2003; (4):CD001964. PubMed ID: 14583942
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues JJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD001964. PubMed ID: 22258947
[TBL] [Abstract][Full Text] [Related]
6. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials.
Mocellin S; Nitti D
Cancer Treat Rev; 2015 May; 41(5):448-54. PubMed ID: 25814393
[TBL] [Abstract][Full Text] [Related]
7. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2004 Oct; (4):CD001964. PubMed ID: 15495024
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
9. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3?
Mogal H; Fields R; Maithel SK; Votanopoulos K
Ann Surg Oncol; 2019 Sep; 26(9):2912-2932. PubMed ID: 31076930
[TBL] [Abstract][Full Text] [Related]
10. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.
Jiang L; Yang KH; Guan QL; Zhao P; Chen Y; Tian JH
J Surg Oncol; 2013 Jun; 107(8):807-14. PubMed ID: 23512524
[TBL] [Abstract][Full Text] [Related]
11. Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial.
Kulig J; Popiela T; Kolodziejczyk P; Sierzega M; Szczepanik A;
Am J Surg; 2007 Jan; 193(1):10-5. PubMed ID: 17188080
[TBL] [Abstract][Full Text] [Related]
12. Gastric cancer: Current status of lymph node dissection.
Degiuli M; De Manzoni G; Di Leo A; D'Ugo D; Galasso E; Marrelli D; Petrioli R; Polom K; Roviello F; Santullo F; Morino M
World J Gastroenterol; 2016 Mar; 22(10):2875-93. PubMed ID: 26973384
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of D2 lymphadenectomy versus D2 with para-aortic nodal dissection for advanced gastric cancer.
Wang Z; Chen JQ; Cao YF
World J Gastroenterol; 2010 Mar; 16(9):1138-49. PubMed ID: 20205287
[TBL] [Abstract][Full Text] [Related]
14. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
15. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.
Cuschieri A; Fayers P; Fielding J; Craven J; Bancewicz J; Joypaul V; Cook P
Lancet; 1996 Apr; 347(9007):995-9. PubMed ID: 8606613
[TBL] [Abstract][Full Text] [Related]
16. Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery.
Kung CH; Tsai JA; Lundell L; Johansson J; Nilsson M; Lindblad M
BJS Open; 2020 Jun; 4(3):424-431. PubMed ID: 32129948
[TBL] [Abstract][Full Text] [Related]
17. Lymph node dissection in resectable advanced gastric cancer.
de Steur WO; Dikken JL; Hartgrink HH
Dig Surg; 2013; 30(2):96-103. PubMed ID: 23867585
[TBL] [Abstract][Full Text] [Related]
18. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
19. Extended lymphadenectomy in elderly and/or highly co-morbid gastric cancer patients: A retrospective multicenter study.
Rausei S; Ruspi L; Rosa F; Morgagni P; Marrelli D; Cossu A; Cananzi FC; Lomonaco R; Coniglio A; Biondi A; Cipollari C; Graziosi L; Fumagalli U; Casella F; Bertoli P; di Leo A; Alfieri S; Vittimberga G; Roviello F; Orsenigo E; Quagliuolo V; Montemurro S; Baiocchi G; Persiani R; Bencivenga M; Donini A; Rosati R; Sansonetti A; Ansaloni L; Zanoni A; Galli F; Dionigi G;
Eur J Surg Oncol; 2016 Dec; 42(12):1881-1889. PubMed ID: 27266816
[TBL] [Abstract][Full Text] [Related]
20. Do patients with pN0 gastric cancer benefit from prophylactic extended lymphadenectomy?
Sun D; Gong R; Wu H
Surg Oncol; 2012 Mar; 21(1):e7-11. PubMed ID: 22071221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
